IDIVAL researcher Julio Pascual receives the Juan María Parés 2023 Research Award from the UC Social Council

11 de March de 2024

The scientist considers that “this recognition should serve as an incentive to promote, even more, the interest in research among the professionals of the Marqués de Valdecilla University Hospital”. Julio Pascual Gómez, head of the ‘Clinical and Genetics of Headaches’ group at the Valdecilla Research Institute (IDIVAL) and head of the Neurology Service at the […]

Read more →

The UC-IDIVAL Photonics Engineering group will develop a technological platform focused on healthy aging

7 de March de 2024

The initiative is formed by a consortium between IDIVAL, the Ámbar Group and the University of Cantabria The scientific director of the Marqués de Valdecilla Health Research Institute (IDIVAL), Marcos López-Hoyos; the rector of the University of Cantabria (UC), Ángel Pazos; and the president of Grupo Ámbar, Pablo Gómez, presented yesterday, together with the researcher […]

Read more →

The Group of Neurodegenerative Diseases at IDIVAL reveals factors that may influence early diagnosis of Alzheimer’s disease

8 de February de 2024

Previous hypertension, diabetes and renal insufficiency could alter plasma markers A multidisciplinary research team belonging to the Neurodegenerative Diseases Group of IDIVAL and the Cognitive Impairment Unit of the Neurology Service of the Marqués de Valdecilla University Hospital (HUMV) has conducted a study aimed at understanding how different physiological variables and previous diseases could influence […]

Read more →

International visibility of IDIVAL researchers

3 de January de 2024

portal point to a high visibility of IDIVAL authors with more than 62,000 citations of articles published in the period 2018-2022. In this way, the Valdecilla brand exceeds 280,000 citations since its creation. Of note in the period 2018-22 are the citations of papers published in the areas of Immunology (1,383 citations), Pharmacology (1,307 citations) […]

Read more →

IDIVAL participates in an international project on public health

10 de August de 2023

It will allow Cantabria to implement pilot initiatives to promote healthier environments and reduce social inequalities   The EU recently approved a proposal for a Joint Action for the prevention of Cancer and other Non Communicable Diseases (NCDs) with an amount of 75 million euros, which makes it a landmark initiative in public health. A […]

Read more →

The IDIVAL Surgical Innovation and Research Group, leader in robotic colorectal surgery research at European level

1 de August de 2023

The results of the largest European prospective multicenter study on the surgical treatment of right colon cancer have been published.   The MIRCAST study, an International multicenter project led for the whole of Europe from the IDIVAL Institute, was born in 2018 with the aim of evaluating the different ways of performing intestinal anastomosis after […]

Read more →

A study shows that patients with bimalleolar ankle fractures do not show full recovery at 12 months

20 de July de 2023

Ankle fractures are the third most frequent cause of total fractures and generate functional alterations in the short and long term.   Ankle fractures are the third most frequent cause of fractures in all ages. Surgical treatment and the period of immobilization generate important functional alterations in the short and long term such as pain, […]

Read more →

The deadline for submitting expressions of interest to serve as ISCIII staff evaluators of R&D&I calls for proposals in health is now open

The Instituto de Salud Carlos III (ISCIII) has opened the call for expressions of interest for the identification of people willing to collaborate with the ISCIII in the scientific evaluation of different biomedical and health research calls, such as those related to the Acción Estratégica en Salud (AES) or other external calls that the Institute […]

Read more →

New Flow Cytometer – Cell Separator at IDIVAL with more applications that enhances the scientific capabilities of the Institute

12 de July de 2023

This new equipment expands the possibilities of identification and isolation of cellular and subcellular populations in a more precise way for use in biomedical research projects.   IDIVAL already has a new CELL SEPARATOR (SORTER) in operation with greater functionalities, available both for IDIVAL researchers and external users. Its capacity to measure multiple cell parameters […]

Read more →

IDIVAL researchers continue to analyze the influence of meteorological and geographical factors on the severity of COVID-19

8 de June de 2023

These studies allow to have a better understanding of the seasonality of COVID-19 and to establish future vaccination strategies. Researchers from IDIVAL, Valdecilla Hospital and the University of Cantabria continue to analyze the influence of meteorological and geographical factors on the severity of COVID-19 in order to have a better understanding of the disease, its […]

Read more →